'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows

A Phase 3, 500-person trial pitted the once-a-day pill against standard chemotherapy in patients who had already gone through one unsuccessful round of traditional cancer treatment. The research found the pill, ...


View article...


Top stories of the last 30 days

IN05051 — रेलवे की स्वास्थ्य सेवाओं में डिजिटल क्रांति: अब 100 पेपरलेस होगा इलाज, ई-उम्मीद और HMIS से ...